To determine the feasibility and acceptability of VR SCT on patients and for clinicians and to explore the effect of VR SCT on behaviour, social cognition and social anxiety in people with ASD.
ID
Source
Brief title
Condition
- Developmental disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Acceptability, utility and feasibility of the intervention, measured using
questionnaires and interviews.
Secondary outcome
Social cognitive and neurocognitive outcome measures
Background summary
People with autism spectrum disorder (ASD) commonly experience deficits in
social cognition and social functioning. Social cognition training (SCT) has
been shown to have beneficial effects on social cognition tasks, but
generalization to social functioning in daily life is limited. Current
individual SCT do not seem to be ecologically valid, and patients cannot
practice skills in dynamic social interactions. We propose that this problem
could be solved by providing SCT in Virtual Reality (VR). VR allows for
practice of skills in situations resembling real life, yet remaining safe and
controllable.
Study objective
To determine the feasibility and acceptability of VR SCT on patients and for
clinicians and to explore the effect of VR SCT on behaviour, social cognition
and social anxiety in people with ASD.
Study design
This study is a feasibility study with a patient group with an autism spectrum
disorder. Patients will receive the intervention, baseline post-intervention
and follow-up assessments will be obtained.
Intervention
The VR SCT consists of sixteen sessions, during a 12-week timeframe. Session
lasts 60 minutes. During sessions, social cognition is trained in virtual
environments. The intervention consists of three modules: facial affect
recognition, emotion recognition within a context & theory of mind and
interaction training.
Study burden and risks
Participants will be interviewed and tested at baseline, post intervention, and
at follow-up, with an average total duration of approximately one hour for each
measurement. The intervention will take sixteen hours in total (sixteen
sessions of 60 minutes each). We expect patients to benefit from the therapy by
increasing social cognitive skills. Some patients might experience simulator
sickness symptoms during the therapy. No major adverse events are expected or
have been documented.
Wytemaweg 8
Rotterdam 3015 CN
NL
Wytemaweg 8
Rotterdam 3015 CN
NL
Listed location countries
Age
Inclusion criteria
1. Diagnosis of an autism spectrum disorder, determined by a structured
interview (ADOS/3Di) in the previous three years or a confirmed ASD diagnosis
by a clinician
2. Age 18 * 65
3. Indication of impaired social cognition by the treating therapist
Exclusion criteria
1. An estimated IQ below 70
2. Substance dependence
3. Insufficient proficiency of the Dutch language
4. Presence of a relevant psychiatric or neurological disorder such as
dementia, epilepsy or organic brain damage
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL65384.078.18 |
| Other | Trial NL8069 |